e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Other thoracic tumours, particular circumstances and rare cases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Erlotinib (E) in elderly pts with NSCL: Experience at a tertiary referral center
A. Strimpakos, D. Vassos, A. Vassias, S. Tsimboukis, P. Boura, S. Tsagkouli, M. Zontanos, K. Syrigos (Athens, Greece)
Source:
Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Session:
Other thoracic tumours, particular circumstances and rare cases
Session type:
Thematic Poster Session
Number:
4533
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Strimpakos, D. Vassos, A. Vassias, S. Tsimboukis, P. Boura, S. Tsagkouli, M. Zontanos, K. Syrigos (Athens, Greece). Erlotinib (E) in elderly pts with NSCL: Experience at a tertiary referral center. Eur Respir J 2013; 42: Suppl. 57, 4533
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Bevacizumab (Bv) in elderly pts with NSCLC: Experience at a tertiary referral center
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013
Multidisciplinary management of lung cancer in a university teaching hospital in Algiers
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Survival in lung cancer: Associated factors in Tunisian patients
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Demography and survival in lung cancer patients presenting to the accident and emergency department
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Lung cancer in patients before the age of 45: A retrospective analysis of 62 patients
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Lung cancer: Independent death predictor in cancer patients admitted after emergency visit
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Improving survival for NSCLC patients in the national lung cancer audit
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Predictors of lung cancer patients delay time in Serbia - a cross-sectional study
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Oncologic emergencies in patients monitored for lung cancer in the Bab-El-Oued University Hospital
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Assesment of palliative care in lung cancer in Turkey (ASPECT study)
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015
Futile thoracotomy in lung cancer
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
A survey of outcome of CT guided lung biopsies in a tertiary centre
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Treatment of advanced non-small cell lung cancer with trofosfamide
Source: Annual Congress 2013 –Advances in the therapy of lung cancer
Year: 2013
Diagnosing lung cancer: Choosing the best for your patient
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Reducing the rate of emergency presentation in lung cancer
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Surgical treatment outcomes on early-stages of non-small-cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Reduced perioperative mortality after centralization of lung cancer surgery
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Lung cancer in women: What are particularities?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Symptom occurrence in lung cancer patients prior to surgery
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013
Lung cancer, has it changed in the last ten years?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept